| 46.05 Data as of Jun 19 |  -0.80 / -1.71%Today’s Change | 30.64 Today|||52-Week Range 49.57 | +41.30% Year-to-Date |
| Bristol-Myers Squibb (BMY) Adds Harmon's Paliwal to Board Jun 19 / Investing Channel | Data on BMY/ AbbVie's elotuzumab - Analyst Blog Jun 17 / Zacks.com |
| Bristol-Myers Squibb Company (BMY): Today's Featured Health Care Laggard Jun 19 / TheStreet.com | 1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask) Jun 14 / MotleyFool.com |
| The Diabetes Drug War Jun 19 / MotleyFool.com | A Trio of Cancer Immunotherapy Innovators Jun 14 / MotleyFool.com |
| The Best Healthcare Bet Jun 18 / MotleyFool.com | Bristol-Myers, Simcere Announce Partnership to Co-Develop, Co-Commercializde Orencia ... Jun 14 / Benzinga |
| Simcere Ties Up with Bristol-Myers - Analyst Blog Jun 17 / Zacks.com | Biotech Stock Mailbag: Exact Sciences, Questcor, Biotech M&A, Celsion Jun 14 / TheStreet.com |
| Previous close | 46.85 |
| Today’s open | 46.60 |
| Day’s range | 46.03 - 47.03 |
| Volume | 7,827,558 |
| Average volume (3 months) | 11,178,839 |
| Market cap | $77.0B |
| Dividend yield | 3.04% |
| Earnings growth (last year) | -46.30% |
| Earnings growth (this year) | -8.58% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | -17.05% |
| P/E ratio | 52.9 |
| Price/Sales | 3.09 |
| Price/Book | 5.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk A/S | -3.11 | -1.92% |
| ABBVAbbVie Inc | -0.50 | -1.15% |
| AZNAstraZeneca PLC | -0.79 | -1.55% |
| LLYEli Lilly and Co | -0.98 | -1.87% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $17.6B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 11.12% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Director Lamberto Andreotti |
Chief Financial Officer & Executive Vice President Charles A. Bancroft, MBA, CPA |
Corporate headquarters New York, New York |
.
